Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bioluminescent Technology Verifies Endoscope Cleanliness

By HospiMedica International staff writers
Posted on 07 Aug 2017
A new testing system provides real-time verification of the cleanliness of endoscopes and other reusable medical instruments in just 15 seconds.

The Hygiena (Camarillo, CA, USA) EndoSwab is a single use, catheter-like device that features an absorbent sponge tip attached to a 2.4 meter long flexible wand, enabling sample collection from even hard-to-reach internal channels and components. More...
Following swabbing sampling, the sponge tip is removed and assessed using proprietary adenosine triphosphate (ATP) test devices. Since ATP is a component of all bodily fluids, the test can verify the cleanliness--but not the sterility--of the endoscope. Once the initial cleaning steps have been confirmed, the instrument can then be disinfected, sterilized, and reused.

EndoSwab is compatible with the Hygiena UltraSnap and SuperSnap ATP surface test devices, two fully integrated, easy-to-use and environmentally-friendly systems capable of generating highly sensitive, accurate and reproducible results using a luminometer. Similarly, the Hygiena AquaSnap device can be used to verify water quality. The systems incorporate a software package for the recording of test data, which can then be used to generate graphs and reports that detect cleaning issues, identify personnel training needs, and monitor the overall cleanliness of an instrument inventory over time.

“Owing to the invasive nature of the procedures in which they are used, reusable medical devices are highly susceptible to contamination. As such, proper reprocessing between uses is necessary to avoid cross-contamination and infection outbreaks,” said Martin Easter, PhD, chief scientific officer of Hygiena. “EndoSwab allows for the easy collection of test samples on a daily basis and the rapid detection of contamination before patient exposure.”

ATP is a key factor of the bioluminescent reaction, a multistep process which mainly requires luciferine substrate, Oxygen (O2), Magnesium cation (Mg++) and ATP. The process relies on luciferine oxidation, with light intensity directly proportional to ATP content. The light emission is a consequence of a rapid loss of energy of the oxyluciferine molecule from an excited state to a stable one, a reaction that induces the emission of photons with an efficient quantum yield of about 90%.

Related Links:
Hygiena


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.